Intrinsic Value of S&P & Nasdaq Contact Us

HeartSciences Inc. HSCSW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
28/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

HeartSciences Inc. (HSCSW) reported total assets of $4.22M and total liabilities of $4.02M for fiscal year 2025, resulting in total equity of $205.17K.

The company held $1.1M in cash and short-term investments. Total debt stood at $2.99M, with net debt of $1.89M. The Debt-to-Equity (D/E) ratio was 14.55 (leveraged).

Current ratio is 0.59, which may signal tight short-term liquidity. Interest coverage is -16.7x (weak).

Criteria supported by this page:

  • HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
  • MOAT (0/100) — Total assets $4.22M and equity $205.17K support the company's competitive scale
  • VALUE (100/100) — Debt-to-Equity 14.55 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 27/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
28/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
→ Valuation
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
0/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income
HeartSciences Inc. Balance Sheet History
Metric FY2025 FY2024 FY2023 FY2022
Total Assets $4.22M$9.5M$3.29M$2.09M
Total Liabilities $4.02M$2.19M$3.06M$8.15M
Total Debt $2.99M$1.04M$1.57M$6.16M
Cash & Investments $1.1M$5.81M$1.66M$918.26K
Total Stockholders Equity $205.17K$7.32M$230.56K$-6.06M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message